EVOKE PHARMA, INC. Proceeds from Stock Plans
EVOKE PHARMA, INC. reported Proceeds from Stock Plans of $63.90 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2025-11-13
- EVOKE PHARMA, INC. proceeds from stock plans for the quarter ending 2025-09-30 was $38.90K.
- EVOKE PHARMA, INC. proceeds from stock plans for the quarter ending 2025-06-30 was $0.00.
- EVOKE PHARMA, INC. proceeds from stock plans for the quarter ending 2025-03-31 was $25.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month |
|---|---|---|---|
| 2025-09-30 | $38.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $38.90K derived: sum of 2 quarters · filed 2025-11-13 | $63.90K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $25.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $25.00K 10-Q · filed 2025-05-13 |